(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS ANTI-PDL1 ATIVÁVEIS E MÉTODOS DE USO DOS MESMOS

ArquivadaInvention PatentPCT · US2018035508

Application data

Number

112019025188

Type

Invention Patent

Filing

05/31/2018

Publication

06/23/2020

PCT

US2018035508

Progress at the INPI

  1. Filing05/31/18
  2. Publication06/23/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 12/17/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CYTOMX THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

B. Z. (pessoa física)

US

K. B. (pessoa física)

US

L. C. (pessoa física)

US

M. W. (pessoa física)

US

R. H. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/513,937 · 06/01/2017

US

62/534,950 · 07/20/2017

US

62/555,598 · 09/07/2017

US

62/657,567 · 04/13/2018

Abstract

A invenção refere-se geralmente a anticorpos ativáveis que se ligam especificamente ao PDL1 e a métodos para fabricar e usar estes anticorpos ativáveis anti-PDL1 em uma variedade de indicações terapêuticas, diagnósticas e profiláticas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

12/17/2024

RPI 2815

Parecer de pré-exame

#6.23

08/27/2024

RPI 2799

Adição na publicação

#15.35

11/03/2021

RPI 2652

Notificação de entrada na fase nacional - PCT

#1.3

06/23/2020

RPI 2581

Alteração de dados cadastrais

#1.1

12/10/2019

RPI 2553

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.